|
Drug | Target | Outcome | Comments | Reference |
|
Multiple Targets |
Betulinic acid | Multiple DUBs | Accumulates poly-Ub targets and enhances their degradation via UPS; inhibits PCa cell proliferation and induces apoptosis | Specific in action against cancer cells without affecting normal cells | [5] |
Curcusone D | Multiple DUBs | ROS-induced inhibition of DUBs; growth inhibition and apoptosis of multiple myeloma (MM) cells | Shows synergistic effect with Bortezomib in MM | [6] |
PR-619 | Multiple DUBs | Accumulates polyubiquitinated proteins and enhances proteasomal activity | Small molecule inhibitor | [7] |
Cyclopentenone prostaglandins, dibenzylideneacetone, curcumin, and shikoccin | Cellular isopept-idase | Cell death in colon cancer cells | Very broad spectrum | [8] |
b-AP15 | UCH-L5 USP14 | Blocks proteasome function and promotes tumor cell apoptosis in preclinical models | High specificity | [9] |
P22077 | USP7 USP47 | Induction of apoptosis involving p53 by multiple pathways (Mdm2, Claspin, Tip60, etc.) | Specific small molecule inhibitor | [7, 134] |
WP1130 | USP5 USP9X USP14 UCH-L1 UCH-37 | Decreased Mcl-1, increased p53, stops cell proliferation and induces death in multiple myeloma (MM) and mantle cell lymphoma (MCL) | Poor solubility and pharmacokinetics | [10] |
G9 (a WP1130 derivative) | USP9X USP24 | Decreased Mcl-1, increased p53, induces cell death in MM, MCL and melanoma | Better solubility and lesser toxicity than WP1130 | [10] |
|
Specific Targets |
3-Amino-2-keto-7H-thieno[2,3-b]pyridin-6-one derivatives | UCH-L1 | Moderately potent inhibitors | Does not show activity against other cysteine hydrolases | [11] |
Pimozide and GW7647 | USP1 | Shows synergistic effect with cisplatin in cytotoxicity of NSCLC | Specificity is high | [12] |
2-cyanopyrimidine and triazine derivatives | USP2 | Specific biological data is absent | ā | [8] |
HBX 41,108 | USP7 | Activates p53 and induces apoptosis in cancer cells | Shows some cross-reactivity | [13] |
HBX 19,818 and HBX 28,258 | USP7 | Leads to cell cycle arrest in HCT116 cells | Specific inhibition of catalytic activity | [14] |
Spongiacidin C | USP7 | ā | A natural pyrrole alkaloid | [15] |
HBX 90,397 and HBX 90,659 | USP8 | Induces G1 arrest and inhibits cell growth in HCT116 and PC3 | Small molecule inhibitor | [16] |
9-oxo-9 H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile and analogs | USP8 | Antiproliferative and proapoptotic in cancer cell lines | Selective inhibitor | [17] |
1-[1-(4-fluorophenyl)-2,5-dimethylpyrrol-3-yl]-2-pyrrolidin-1-ylethanone)-IU1 | USP14 | Enhances proteasome function and accelerates proteolysis | Small molecule inhibitor | [18] |
|